Shift Shapers Podcast

31 May 2021

Ep #360: Taming “The Other” Claims Cost Monster – with Surya Singh

David Saltzman 0 Comments

This week’s episode features a conversation with Surya Singh, CEO and Co-founder at gWell. Muskoskeletal claims are growing monster that gobbles up claims spends. Cutting-edge tech in genomics, AI, and machine learning help create diagnostics for the best treatments since many chronic conditions have genetic markers associated with them. At the same time, this technology cuts costs by as much as a third of current spends, a significant percentage that’s of interest to employers and patients alike.

What You’ll Learn From This Episode:

  • 01:57 Surya’s professional background
  • 03:44 Musculoskeletal claims: Rising costs associated with longer lives
  • 06:14 Genomics and genetics help diagnose chronic conditions
  • 13:46 AI and machine learning accurately determine the recovery time of patients
  • 18:46 Genetic testing and genomics cut overall spend by a third


05:06 “People are surviving longer and so after you get that first knee surgery, arthroscopic knee procedure, even a knee replacement or hip replacement, you may outlive it. You may live long enough that you need another one now.”

08:41 “For almost every common chronic disease or condition that develops, there are multiple genes at play. And not only are there multiple genes at play, those genes are expressed, they are used, in different combinations and at different levels by the body.”

15:39 “We can understand which of those pathways are the ones that are leading to better form and function, leading to better phenotypic outcomes for people. Artificial intelligence and machine learning are a way to be able to do that.”

18:22 “Which genetic markers that dictate whether or not they respond well to e-centric exercise, the weight-bearing exercise, and how long their recovery periods are in between can really help dictate are they out from being functional again for 2 weeks or a month or 6 months.”

20:30 “One thing I worry about in terms of making sure that the impact is as broad as it can be in terms of economics and in terms of value, and also to use another little cliche that’s used a lot now, that no one is left behind so to speak.”

Listen to the Full Interview:

This Episode is Sponsored by:

Enjoy The Show?